Christophe Ba - Publications

Efficacy and safety of SENS-501, a dual-AAV otoferlin gene therapy, for DFNB9 congenital deafness.

Journal: Molecular therapy. Advances

Published: December 04, 2025

Noise-induced trauma produces a temporal pattern of change in blood levels of the outer hair cell biomarker prestin.

Journal: Hearing research

Published: June 28, 2018

Oral Administration of Clinical Stage Drug Candidate SENS-401 Effectively Reduces Cisplatin-induced Hearing Loss in Rats.

Journal: Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology

Published: August 11, 2017

High Accumulation and In Vivo Recycling of the New Antimalarial Albitiazolium Lead to Rapid Parasite Death.

Journal: Antimicrobial agents and chemotherapy

Published: February 16, 2017

Involvement of Endogenous Brain-Derived Neurotrophic Factor in Hypothalamic-Pituitary-Adrenal Axis Activity.

Journal: Journal of neuroendocrinology

Published: January 09, 2015

New insight into the mechanism of accumulation and intraerythrocytic compartmentation of albitiazolium, a new type of antimalarial.

Journal: Antimicrobial agents and chemotherapy

Published: July 09, 2014

New bis-thiazolium analogues as potential antimalarial agents: design, synthesis, and biological evaluation.

Journal: Journal of medicinal chemistry

Published: January 08, 2013

Potent in vivo anti-malarial activity and representative snapshot pharmacokinetic evaluation of artemisinin-quinoline hybrids.

Journal: Malaria journal

Published: August 22, 2012

Antimalarial and anticancer activities of artemisinin-quinoline hybrid-dimers and pharmacokinetic properties in mice.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: May 10, 2012

Transport and pharmacodynamics of albitiazolium, an antimalarial drug candidate.

Journal: British journal of pharmacology

Published: April 05, 2012

Evaluation of bis-alkylamidoxime O-alkylsulfonates as orally available antimalarials.

Journal: ChemMedChem

Published: February 28, 2012